Interview with the Dean: Small Molecules Show Big PromiseApril 10, 2014
Dr. Laurie H. Glimcher, dean of Weill Cornell Medical College, speaks with Dr. Hazel Szeto, professor of pharmacology. Dr. Szeto's research focuses on mitochondria, the cells' powerhouse. A peptide Dr. Szeto created with a colleague has shown promise in treating what she calls "brownout diseases" -- Alzheimer's, heart failure and diabetes among them -- in which this "power plant" doesn't function properly. In 2006, Dr. Szeto founded the biopharmaceutical company Stealth Peptides. Its first drug candidate, Bendavia, is in clinical trials.